Hormone Therapy, Breast Cancer Risk and the Collaborative Group on Hormonal Factors in Breast Cancer Article
- PMID: 32483802
- PMCID: PMC10316855
- DOI: 10.1055/s-0040-1712941
Hormone Therapy, Breast Cancer Risk and the Collaborative Group on Hormonal Factors in Breast Cancer Article
Conflict of interest statement
The authors have no conflict of interests to declare.
Comment on
-
Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.Lancet. 2019 Sep 28;394(10204):1159-1168. doi: 10.1016/S0140-6736(19)31709-X. Epub 2019 Aug 29. Lancet. 2019. PMID: 31474332 Free PMC article.
References
-
- International Menopause Society. Comment on: Type and timing of menopausal hormone therapy and breast cancer risk: individual participant metaanalysis of the worldwide epidemiological evidence [Internet] 2019. [cited 2020 Mar 22]. Available from: https://www.imsociety.org/manage/images/pdf/5054afeb9b1bc763032333443f1c...
-
- Associação Brasileira de Climatério. Comentário da International Menopause Society sobre o artigo: Type and timing of menopausal hormone therapy and breast cancer risk: individual participant metaanalysis of the worldwide epidemiological evidence [Internet] 2019. [cited 2020 Mar 22]. Available from: http://sobrac.org.br/media/files/publicacoes/00002172_comentario_da_inte...
-
- Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer Lancet 1997350(9084):1047–1059.. Doi: 10.1016/S0140-6736(97)08233-0 - PubMed
-
- Beral V; Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 2003362(9382):419–427.. Doi: 10.1016/s0140-6736(03)14065-2 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical